These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7770096)

  • 1. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
    Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier.
    Saadouni S; Refahi-Lyamani F; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Jul; 268(2):187-97. PubMed ID: 7957640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier.
    Héron C; Billaud G; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1996 Apr; 301(1-3):195-202. PubMed ID: 8773464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
    Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
    Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes.
    Billaud G; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1993 Nov; 247(3):333-40. PubMed ID: 8307105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
    Héron C; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics of the binding of BTCP (GK 13) and related derivatives on the dopamine neuronal carrier.
    Billaud G; Menard JF; Marcellin N; Kamenka JM; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Aug; 268(3):357-63. PubMed ID: 7805759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
    Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
    Valchar M; Hanbauer I
    J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine.
    Do-Régo JC; Hue H; Costentin J; Bonnet JJ
    J Neurochem; 1999 Jan; 72(1):396-404. PubMed ID: 9886093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: attempts to characterize the Na+ dependence of the neuronal transport of dopamine.
    Amejdki-Chab N; Benmansour S; Costentin J; Bonnet JJ
    J Neurochem; 1992 Nov; 59(5):1795-804. PubMed ID: 1402923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
    Vaugeois JM; Bonnet JJ; Costentin J
    Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
    Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
    Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
    Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
    Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935.
    Reith ME; Selmeci G
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):309-18. PubMed ID: 1620235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionic requirements for the specific binding of [3H]GBR 12783 to a site associated with the dopamine uptake carrier.
    Bonnet JJ; Benmansour S; Vaugeois JM; Costentin J
    J Neurochem; 1988 Mar; 50(3):759-65. PubMed ID: 3339350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK
    Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
    Kula NS; Baldessarini RJ
    Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.
    Wilson JM; Nobrega JN; Carroll ME; Niznik HB; Shannak K; Lac ST; Pristupa ZB; Dixon LM; Kish SJ
    J Neurosci; 1994 May; 14(5 Pt 2):2966-79. PubMed ID: 8182452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.